OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
Ester A. Barreto, Amanda Stephane Cruz dos Passos, Flávio P. Veras, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Infection with SARS-CoV-2 can cause pancreatic impairment
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9

Increased hepatic gluconeogenesis and type 2 diabetes mellitus
Emma Barroso, Javier Jurado-Aguilar, Walter Wahli, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 12, pp. 1062-1077
Closed Access | Times Cited: 9

Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15

COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights
Praise Tatenda Nhau, Mlindeli Gamede, Ntethelelo Sibiya
Pathophysiology (2024) Vol. 31, Iss. 2, pp. 197-209
Open Access | Times Cited: 6

SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure
Monu Monu, Ahmad Faraz, Rachel M. Olson, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012156-e1012156
Open Access | Times Cited: 6

Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access

SARS‐CoV‐2 Productively Infects Human Hepatocytes and Induces Cell Death
Chunkyu Ko, Cho‐Chin Cheng, Daniele Mistretta, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access

FABP4 as a therapeutic host target controlling SARS-CoV-2 infection
Hatoon Baazim, Emre Koyuncu, Gürol Tuncman, et al.
EMBO Molecular Medicine (2025)
Open Access

Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Jung Hwan Cho, Sunghwan Suh
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 222-238
Open Access | Times Cited: 4

Non-human primate model of long-COVID identifies immune associates of hyperglycemia
Clovis S. Palmer, Chrysostomos Perdios, Mohamed Abdel‐Mohsen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

The complex landscape of intracellular signalling in protein modification under hyperglycaemic stress leading to metabolic disorders
Hamda Khan, Afreen Khanam, Adnan Ahmad Khan, et al.
The Protein Journal (2024) Vol. 43, Iss. 3, pp. 425-436
Closed Access | Times Cited: 3

Host determinants and responses underlying SARS-CoV-2 liver tropism
Natalie Heinen, Mara Klöhn, Saskia Westhoven, et al.
Current Opinion in Microbiology (2024) Vol. 79, pp. 102455-102455
Open Access | Times Cited: 3

Increased prevalence of cardiovascular-kidney-metabolic syndrome conditions during COVID-19: A propensity score-matched study
Valentina Trimarco, Raffaele Izzo, Daniela Pacella, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111926-111926
Closed Access | Times Cited: 3

PPARγ mediated enhanced lipid biogenesis fuelsMycobacterium tuberculosisgrowth in hepatocytes
Binayak Sarkar, Jyotsna Singh, Mohit Yadav, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
Hatoon Baazim, Emre Koyuncu, Gürol Tuncman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
Yu Zhang, Shihan Chen, Yan Tian, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1

COVID-19 and Diabetes: An Epidemiologic Overview
Jonathan Mannheim, Daniel Y. Johnson
Pediatric Annals (2024) Vol. 53, Iss. 7
Closed Access | Times Cited: 1

Pathological Sequelae of SARS-CoV-2: A Review for Clinicians
Joseph Nyarko, Patience Mawuena Dogbe, Lawrencia Ami Emefa Ativi, et al.
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 4, pp. 431-445
Open Access | Times Cited: 1

Temporal analysis of hospitalizations for Diabetes Mellitus in Brazil and its relationship with COVID-19: ecological study
Amanda Chabrour Chehadi, Beatriz da Silva Morandi, Gelma Maria Jerônymo Vieira Neves, et al.
Contribuciones a las Ciencias Sociales (2024) Vol. 17, Iss. 2, pp. e4078-e4078
Open Access

Diabetes and COVID-19 Outcomes: An Analysis of Freeman Health System Patients
Timothy Wiant, L. Schmidt, SaiBhavana Srikakolapu, et al.
Cureus (2024)
Open Access

Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access

[Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia].
Juan Xia, Lijuan DU, Xueli Xi, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 230-235
Closed Access

Page 1 - Next Page

Scroll to top